If you talk to cancer researchers about barriers to scientific progress, you’ll probably hear this statistic: Only about 8% of people with cancer actually take part in clinical trials.
This being 2019, a lot of people think the problem can be solved with mobile apps that connect patients to the trials that might be right for them. But — this being 2019 — the use of such technology raises some thorny questions about privacy, consent, and conflict of interest.
